[1] LOH KC, KOAY ES, KHAW MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore[J]. J Clin Endocrinol Metab,2000,85(8):2854.
[2] MULATERO P,DLUHY RG,GIACCHETTI G,et al. Diagnosis of primary aldosteronism:from screening to subtype differentiation[J]. Trends Endocrinol Metab,2005,16(3):114.
[3] SAHAR DE,YANG GP,LONGAKER MT,et al. Surgical applicationof cDNA microarray technique[J]. Surgery,2005,138(3):399.
[4] MILAN A,PUGLISI E,MAGNINO D,et al. Left atrial enlargement in essential hypertension:role in the assessment of subclinical hypertension heart disease[J]. Blood Press,2012,21(2):88.
[5] BIECHE I, VACHER S, VALLERAND D, et al. Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays:evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings[J]. BMC Cancer,2014,14(1):173.
[6] TAKEKOSHI K, ISOBE K, YASHIRO T. et al. Expression of vascular endothelial growth factor(VEGF) and its cognate receptors in human pheochromocytomas[J]. Life Sci,2004,74(7):863.
[7] GORRIGAN RJ,GUASTI L,KING P,et al. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland[J]. Mol Endocrinol,2011,46(3):227.
[8] STRZALKA W. ZIEMIENOWICZ A. Proliferating cell nuclear antigen(PCNA):a key factor in DNA replication and cell cycle regulation[J]. Ann Bot,107(7):1127.